These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra. Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084 [TBL] [Abstract][Full Text] [Related]
5. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome. Koné-Paut I; Galeotti C Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542 [TBL] [Abstract][Full Text] [Related]
6. [Update in interleukin-1 inhibition]. de Boysson H Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831 [No Abstract] [Full Text] [Related]
7. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene. Iida Y; Wakiguchi H; Okazaki F; Nakamura T; Yasudo H; Kubo M; Sugahara K; Yamashita H; Suehiro Y; Okayama N; Hashimoto K; Iwamoto N; Kawakami A; Aoki Y; Takada H; Ohga S; Hasegawa S Clin Rheumatol; 2019 Mar; 38(3):943-948. PubMed ID: 30338413 [TBL] [Abstract][Full Text] [Related]
8. [Muckle-Wells syndrome caused by a new cryopyrin mutation: effective treatment with interleukin-1 antagonist]. Rameev VV; Kozlovskaia LV; Bogdanova MV Ter Arkh; 2012; 84(6):53-9. PubMed ID: 22997920 [TBL] [Abstract][Full Text] [Related]
20. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment. Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]